skip to main content
pulmonology & sleepscoring tool

BODE Index (COPD Prognosis)

iatroX editorial team · Updated · Record checked · editorial policy

The BODE index is a multidimensional COPD prognostic score incorporating Body mass index, airflow Obstruction (FEV₁), Dyspnoea (mMRC), and Exercise capacity (6MWD). It predicts mortality better than FEV₁ alone.

inputs

Low BMI in COPD reflects muscle wasting and is an independent mortality predictor
evidence

derivation

Developed by Celli et al. (NEJM 2004) from 625 COPD patients followed for up to 5 years at multiple centres.

validation

BODE predicted mortality better than FEV₁ alone (AUROC 0.74 vs 0.65). BODE quartile 4 (7–10) had 80% 4-year mortality vs 20% for quartile 1 (0–2). Validated in multiple international cohorts. Used in transplant referral guidelines.

guideline endorsements

GOLD 2025 Report references BODE for prognosis. ISHLT transplant listing guidelines reference BODE ≥5–6. ATS/ERS COPD outcome measures reference BODE.

references
  1. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM. 2004;350(10):1005-1012.PMID: 14999112
  2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2025 Report.link ↗